CEO of Fortify Health, Mulago and Jacobs Fellow, Ex-IDinsight and Management Consulting.
I lead Fortify Health, a GiveWell, Coefficient Giving and Founder's Pledge supported non-profit dedicated to reducing and preventing iron-deficiency anaemia. I love thinking about how to scale impactful, evidence-based, cost-effective interventions to alleviate poverty.
Thanks Christophe for sharing these thoughts. I would flip this discussion somewhat, as you note (and which I agree with).
"I've recently talked with a charity founder: Their cost effectiveness was lower than that of their "competitor" because their competitor paid themselves a lower salary. This is a race to the bottom that is unhealthy for the movement. The problem is, of course, that this can't be done by one charity alone. This would negatively impact their cost effectiveness when compared to others. ... Best thing to try probably is for large donors to start requiring this from their charities and thereby change the standard. For that the donors need to accept that their reported impact will go down."
The example you raise is a good one, but for me it points to an inefficiency in how donors measure effectiveness rather than in how organisations set salaries. Within a standard cost-effectiveness calculation, there's a direct incentive for organisations to underpay senior staff, particularly founders. For smaller organisations with budgets in the range of $300-500k, two co-founders paying themselves a living wage of $30-40k instead of a market rate of $80-100k generates savings of $80-140k. That's a reduction in total costs of roughly 25%, which inflates reported cost-effectiveness by a corresponding amount, entirely artificially.
This creates three real problems. First, it distorts comparisons between organisations at the early stage, potentially directing funding toward interventions that look cost-effective partly because their founders are financially sacrificing. Second, and relatedly, it penalises organisations that pay fair salaries, which is the race to the bottom you're describing. Thirdly, it can curtail individuals, who may otherwise have a great incentive in donating to other high-impact causes to actually do so.
My view is that researchers conducting cost-effectiveness analyses have a role to play here: benchmarking standardised market rates for senior staff, independent of what individuals actually choose to pay themselves. This would remove the artificial incentive, give organisations flexibility to determine their own compensation, and allow any differential between market rate and actual salary to be treated as what it effectively is: a donation. The linked EA Forum piece makes this case well.
I recognise this is a longer-term structural shift and harder to move than individual donor preferences. But I think a lot of what you're describing is downstream of this measurement problem, and that's where the leverage is.
Hey Svetha - I have a lot of admiration for what you and your team have built at New Incentives. A couple of questions:
1. Could you describe how New Incentives has used evidence throughout its history to inform strategic pivots / changes to its intervention, and what you have learned from this process?
2. The KPIs and cost-effectiveness figures that New Incentives has achieves are remarkable. What has it taken (that may not be visible in these numbers) to build an organisation and foster a team to achieve these results? What are some generalisable learnings / frameworks that may assist other organisations in their growth / scaling journeys?
3. I understand that New Incentives is listed as one of GiveWell's Top Charities which I assume helps with bringing in significant philanthropic support. From my experience at the recent Skoll Conference, there is a lot of discussion right now of engaging with government as the doers and payers at scale - particularly as philanthropy has gone through a recent sea-change. Are you thinking about sustainability and engagement with government as a route to further scale, or is the current model of philanthropic support the major vector that you see for ongoing scaling of your intervention?
Hi Mark — thank you for the detailed response and for sharing the steps GiveWell is already taking on monitoring implementation fidelity. All of this is very encouraging, particularly the moves toward real-time identification and resolution of issues at the grantee level.
One area I'd love to hear more about is the following:
"Ensuring grantees are adequately monitoring critical activities. We've made it standard practice to identify the critical activities required for the desired impact and to ensure grantees have plans for monitoring these in real-time and addressing issues quickly."
I think this is one of the most important levers available. Internal grantee monitoring, when done well, is likely to be the fastest and most cost-effective feedback mechanism. External evaluation processes generate valuable information, but they are almost always slower and more resource-intensive. Beyond improving grantmaking decisions directly, I'd expect this to have an indirect benefit: making M&E expectations explicit and visible tends to strengthen internal M&E culture within organisations over time.
What I'd be curious about is whether GiveWell has considered moving toward some degree of transparent standardisation of what "monitoring critical activities" actually looks like in practice — for instance, a shared framework defining what grantees are expected to track, at what frequency, and how findings should be acted on.
Is this something GiveWell is actively developing, and if so, is there scope for that framework to be shared more publicly?
This is a thoughtful framework, and I broadly find the approach reasonable. One dimension I'd like to see explored further, though, is the risks embedded in using collective user preference as the mechanism for determining what counts as "prosocial."
The post rightly flags the challenge of identifying uncontroversial prosocial actions, and grounding this in aggregated user preferences is an intuitive starting point. But collective preference carries well-documented risks, including majoritarian bias, and what users collectively want may not align with what is genuinely beneficial for minority groups or for society in the long run. The history of democratic theory gives us good reason to be cautious here.
This raises a question I'd genuinely like to hear views on: to what extent should formal governance structures, including governments and their regulatory capacity, play a role in defining the boundaries of prosocial AI behaviour? I recognise the practical complexity here, particularly given the current fragmented state of AI governance globally. But philosophically, democratically accountable institutions offer something that collective user preference alone cannot: legitimacy derived from deliberative processes, legal accountability, and explicit protections for minority interests.
I'm not arguing that regulation is a clean solution. But it might serve as a useful complementary layer to user preference aggregation, providing a check against the most significant failure modes of purely preference-based approaches.
Thanks for sharing this post. I appreciated the honest behind-the-scenes look at what is involved in being a grant maker.
As someone not working in the AI safety space, I'm intrigued by your opinions as to what extent grant making within AI safety is similar to and different from grant making within other cause priority areas, for example animal advocacy and global development and health?
My sense from reading the post is that those areas may be relatively less neglected, with fewer opportunities for identifying opportunities with outsized impact returns on investment. Do you think that is a reasonable assumption to be making?
Many exciting ideas here - thanks very much for sharing.
From an initial read, there seem to be a lot of similarities to the approach taken by Ambitious Impact's Charity Entrepreneurship Program. Would you be able to share a little bit of context about how this program compares and contrasts to Ambitious Impact, aside from, of course, the geographic focus on Latin America?
Aside from financial donations, are there other ways to support these organizations? I'm thinking in particular in terms of providing advisory support or connections.
Finally, is it possible to share a little bit of context about the meta organization leading this incubation program, and in particular any details on any track record from prior cohorts, if conducted?
Thanks for raising this. I agree strongly with your sentiment.
Sharing some of my quick opinions on the topic: The forum is like any other marketplace, requiring both sufficient demand and supply to drive meaningful engagement and discourse. To drive interest, there need to be incentives on both sides. Here I consider demand to be those reading and engaging with material, and supply to be those seeding new ideas and pushing the discourse forward.
My sense is that GHD has seen systematic shifts over the past couple of years from both the supply and demand side, as the data-driven or evidence-backed component of global health and development has become more mainstream. On the supply side, many organizations that would formerly be considered EA global health and development organizations are becoming more mainstream. Also from a supply side perspective, my anecdotal experience is that a lot of engagement is associated with building eminence, often related to seeking funds or finding jobs, and both of these purposes have found newer, more targeted spaces elsewhere. Seeing the plethora of organizations supporting impact-focused job searches and new, more professionalized funding mechanisms.
Finally, the level of philosophical discourse around GHD has shifted in the past couple of years, especially as the philanthropic sector has seen massive changes, combined with a relative increase in marginal EA funding being directed towards other cause priority areas, particularly AI safety.
All this being said, I personally hope to engage more with GHD on this forum, both on the demand and supply side. I find it an incredibly intellectually stimulating area with values-aligned individuals, and I hope that this kind of seeding, as you've suggested, can drive more engagement with global health and development within EA.
Thanks for sharing - I think that the idea of making GiveWell's CEAs more interactive and approachable is fantastic. Right now, I think many of us implicitly trust GiveWell's transparent process and the mighty individuals who are willing to engage in depth and red-team critical CEAs. However, I do believe that in order for cost-effectiveness to become a norm in the philanthropic sector, approachability is critical.
Would you be open to piloting an extension of this approach with other organisations and interventions that may not be on GiveWell's top recommended list but for whom they have prepared rigorous CEAs. I lead an organisation called Fortify Health that falls into this category and would love to see if there is a way we may be able to collaborate on an extension of this methodology and tool?
From your experience, are there systematic or structural differences in the effective altruism and evidence-based development communities in Australia compared to other high-income Western countries? If so, what do you think drives those differences, and how has your approach to communications and engagement within Australia adapted as a result?
My hypothesis is that Australia's relative geographic isolation, and perhaps certain historic patterns of broader insularity, may mean that global development and health topics require a different kind of conversation to build empathy for places that feel more distant. This is speculative, though, so I'd genuinely welcome your perspective.